Name: Maria Sofia F. Tuala BSN3-B Date: Sep.

23, 2023
Clinical Instructor: Michael T. Mirate RN, MAN
Brand Name: INDICATION CONTRAINDIC DOSAGE ADVERESE NURSING
Evaprost ATION REACTION REPOSIBILITIES
Treatment of IM Initially
postpartum Hypersensitivity 250 mcg. The adverse effects Assessment & Drug
Generic: hemorrhage due to carboprost or Max: 2 mg in observed during the Effects:
Carboprost to uterine atony any of the intervals of use of Evaprost for Monitor uterine
contractions and observe
trometamol which has not components of 15-90 min. abortion and for and report excessive
responded to Evaprost. Acute hemorrhage, not all vaginal bleeding and
Classification: conventional pelvic of which are clearly cramping pain. Save all
Belongs to the methods of inflammatory drug-related, in clots and tissue for
class of management. disease; decreasing order of physician inspection and
prostaglandins. laboratory analysis.
Prior treatment patients with frequency include: Check vital signs at
Used to induce should include active cardiac, Vomiting, diarrhea, regular intervals.
abortion or the use of pulmonary, nausea, flushing or Carboprost-induced febrile
augment labour oxytocin IV, renal or hepatic hot flashes, chills or reaction occurs in more
and to minimize manipulative disease. shivering, coughing, than 10% of patients and
blood loss from must be differentiated from
techniques eg, headaches, endometritis, which occurs
the placental uterine massage endometritis, around third day after
site. and, unless hiccough, abortion.
contraindicated dysmenorrhea-like Patient & Family
IM ergot pain, Education
Report promptly onset of
preparations. bleeding, foul-smelling
discharge, abdominal pain,
or fever.
Since ovulation may
reoccur as early as 2 wk
post-abortion, you may
wish to consider
appropriate contraception.
Do not breast feed while
taking this drug.

Reference: https://www.mims.com/philippines/drug/info/evaprost?type=full
Name: Maria Sofia F. Tuala BSN3-B Date: Sep. 23, 2023
Clinical Instructor: Michael T. Mirate RN, MAN

Reference: https://www.mims.com/philippines/drug/info/evaprost?type=full